Medicine
Dicyclomine 10 mg capsule
Dicyclomine 10 mg capsule is a generic prescription medicine for oral use, made by 29 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Dicyclomine
- Brand
- Sold under the generic name
- Strength
- 10 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 1000 capsules, 500 capsules and 127 more
- Manufacturers
- Camber PharmaceuticalsIndiaAurobindo PharmaIndiaA-S Medication SolutionsAdvagen PharmaHikma PharmaceuticalsLannettSolco HealthcareActavis PharmaRising Pharma HoldingsSolaris Pharma29 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A03AA07 Dicyclomine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 1974
- Identifiers
- RxCUI 991061, 991086DailyMed set ID a66aa5c7-1fde-42fc-9e1f-7f4cc9adac9c, 5eee0dff-d157-4534-adfb-c035b7042c07, d0954a7a-812b-487e-8c22-2a2a58303277 +37NDC 72888-105, 0904-6987, 43547-634 +37Application ANDA216515, ANDA084285, ANDA217531 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 29 labelers. The register lists 130 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 59651-719-01 | Aurobindo PharmaIndia | 8 May 2023 |
| 1000 capsule in 1 bottle | 59651-719-99 | Aurobindo PharmaIndia | 8 May 2023 |
| 100 capsule in 1 bottle | 31722-052-01 | Camber PharmaceuticalsIndia | 1 July 2024 |
| 500 capsule in 1 bottle | 31722-052-05 | Camber PharmaceuticalsIndia | 1 July 2024 |
| 1000 capsule in 1 bottle | 31722-052-10 | Camber PharmaceuticalsIndia | 1 July 2024 |
| 100 capsule in 1 bottle, plastic | 0054-0748-25 | Hikma Pharmaceuticals | 5 June 2023 |
| 1000 capsule in 1 bottle, plastic | 0054-0748-31 | Hikma Pharmaceuticals | 5 June 2023 |
| 100 capsule in 1 bottle, plastic | 0054-0883-25 | Hikma Pharmaceuticals | 15 September 2026 |
| 1000 capsule in 1 bottle, plastic | 0054-0883-31 | Hikma Pharmaceuticals | 15 September 2026 |
| 100 capsule in 1 bottle, plastic | 0591-0794-01 | Actavis Pharma | 19 June 1986 |
| 1000 capsule in 1 bottle, plastic | 0591-0794-10 | Actavis Pharma | 19 June 1986 |
| 1000 capsule in 1 bottle | 72888-105-00 | Advagen Pharma | 17 July 2026 |
| 100 capsule in 1 bottle | 72888-105-01 | Advagen Pharma | 17 July 2026 |
| 500 capsule in 1 bottle | 72888-105-05 | Advagen Pharma | 17 July 2026 |
| 30 capsule in 1 bottle | 72888-105-30 | Advagen Pharma | 17 July 2026 |
| 90 capsule in 1 bottle | 62135-718-90 | Chartwell RX | 26 July 2023 |
| 100 capsule in 1 bottle | 0527-0586-01 | Lannett | 30 September 1974 |
| 500 capsule in 1 bottle | 0527-0586-05 | Lannett | 30 September 1974 |
| 1000 capsule in 1 bottle | 0527-0586-10 | Lannett | 30 September 1974 |
| 100 capsule in 1 bottle | 16571-260-01 | Rising Pharma Holdings | 23 June 2025 |
| 1000 capsule in 1 bottle | 16571-260-10 | Rising Pharma Holdings | 23 June 2025 |
| 100 capsule in 1 bottle | 73473-800-01 | Solaris Pharma | 10 June 2025 |
| 1000 capsule in 1 bottle | 73473-800-10 | Solaris Pharma | 10 June 2025 |
| 100 capsule in 1 bottle | 43547-634-10 | Solco Healthcare US,LLC | 23 August 2022 |
| 1000 capsule in 1 bottle | 43547-634-11 | Solco Healthcare US,LLC | 23 August 2022 |
| 500 capsule in 1 bottle | 43547-634-50 | Solco Healthcare US,LLC | 23 August 2022 |
| 100 capsule in 1 bottle | 24979-201-01 | Upsher-Smith Laboratories | 1 February 2023 |
| 1000 capsule in 1 bottle | 24979-201-03 | Upsher-Smith Laboratories | 1 February 2023 |
| 30 capsule in 1 bottle | 50090-0126-0 | A-S Medication Solutions | 28 November 2014 |
| 60 capsule in 1 bottle | 50090-0126-2 | A-S Medication Solutions | 28 November 2014 |
| 90 capsule in 1 bottle | 50090-0126-8 | A-S Medication Solutions | 28 November 2014 |
| 30 capsule in 1 bottle | 50090-0127-0 | A-S Medication Solutions | 19 December 2014 |
| 28 capsule in 1 bottle | 50090-0127-1 | A-S Medication Solutions | 28 November 2014 |
| 30 capsule in 1 bottle | 50090-7340-0 | A-S Medication Solutions | 16 October 2024 |
| 60 capsule in 1 bottle | 50090-7340-2 | A-S Medication Solutions | 16 October 2024 |
| 90 capsule in 1 bottle | 50090-7340-8 | A-S Medication Solutions | 16 October 2024 |
| 28 capsule in 1 bottle | 50090-7341-1 | A-S Medication Solutions | 16 October 2024 |
| 30 capsule in 1 bottle | 50090-7729-0 | A-S Medication Solutions | 27 October 2025 |
| 60 capsule in 1 bottle | 50090-7729-2 | A-S Medication Solutions | 27 October 2025 |
| 90 capsule in 1 bottle | 50090-7729-8 | A-S Medication Solutions | 27 October 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 May 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dicyclomine
Clinical summary
Dicyclomine is an anticholinergic indicated for the treatment of patients with functional bowel/irritable bowel syndrome. It is available as tablets, capsules and injection for oral and intramuscular use. MedsAcross supplies Dicyclomine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DicyclomineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dicyclomine hydrochloride prescribing information (Advagen Pharma) · U.S. National Library of Medicine, DailyMed
Need Dicyclomine 10 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.